Role of the HIV/AIDS case manager: Analysis of a case management adherence training and coordination program in North Carolina

AIDS Patient Care and STDs

Volumn 20, Issue 3, 2006, Pages 193-204

  Shelton, Rachel C ^a,d   Golin, Carol E ^a,b,e   Smith, Scott R ^c   Eng, Eugenia ^a   Kaplan, Andrew ^b  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADHERENCE COORDINATING SERVICE; ARTICLE; CASE MANAGEMENT; CASE MANAGER; CLINICAL ARTICLE; DRUG RESISTANCE; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; INTERVIEW; MEDICAL EDUCATION; NORMAL HUMAN; PATIENT COMPLIANCE; PROFESSIONAL KNOWLEDGE; PUBLIC HEALTH; REIMBURSEMENT; TREATMENT PLANNING; UNITED STATES;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE OF HEALTH PERSONNEL; CASE MANAGEMENT; EDUCATION; FEMALE; FOCUS GROUPS; HIV INFECTIONS; HUMANS; MALE; NORTH CAROLINA; PATIENT COMPLIANCE; SOCIAL SUPPORT;

EID: 33645332620     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.193     Document Type: Article

References (68)

1. Bangsberg D, Hecht F, Charlebois E, et al. Adherence to protease inhibitors, HIV-1 viral load, and the development of drug resistance in an indigent population. AIDS 2000;14:357-366.
2. Bartlett J, DeMasi R, Quinn J, Moxham C, Rousseau F. Correlation between antiretroviral pill burden and durability of virologie response: A systematic overview [Abstract No 4998]. Poster presented at the 13th International AIDS Conference. Durban, 2000.
3. Golin C, Liu H, Hays R, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 2002;17:1-10.
4. Liu H, Golin C, Miller, L, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-977.
5. Paterson D, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infections. Ann Intern Med 2000;133:21-30.
6. Singh N, Herman S, Swindells S, et al. Adherence of human immunodeficiency of virus-infected patients to antiretroviral therapy. Clin Infect Dis 1999;29: 824-830.
7. Wahl L, Nowak M. Adherence and drug resistance: Predictors for therapy outcome. Proc R Soc Lond B Biol Sci Series B Biol Sci 2000;267:835-843.
8. Carpenter C, Cooper D, Fischl M, et al. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel. JAMA 2000; 283:381-390.
9. Chow R, Chin T, Fong I, Bendayan R. Medication use patterns in HIV-positive patients. Can J Hosp Pharm 1993;46:171-175.
10. Deeks S, Hecht F, Swanson M, et al. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapies. AIDS 1999;13:F35-43.
11. Eldred L, Wu, A, Chaisson, R, Moore, R. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:117-125.
12. Bangsberg D, Perry S, Charlebois E, Perry S, Robertson M, Moss, A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15:1181-1183.
13. Hirsch M, Conway B, D'Aquila, R, et al. Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management. JAMA 1998;279:1984-1991.
14. Kaplan AH, Michael SF, Wehbie RS, et al. Selection of multiple HIV-1 variants with decreased sensitivity to an inhibitor of the viral protease. Proc Natl Acad Sci 1994;91:5597-5601.
15. Nieuwkirk P, Sprangers M, Burger D, et al. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med 2001;161:1962-1968.
16. Eron JJ, Vernazza PL, Johnston DM, et al. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: Implications for transmission. AIDS 1998; 12:F181-F189.
17. Wainberg M, Friedland G. Implications of antiretroviral therapy and HIV drug resistance. JAMA 1998;279:1977-1983.
18. Singh N, Squire C, Sivek M, Wagener M, Hong-Nguyen M, Yu V. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care 1996;8:262-269.
19. Stein M, Rich J, Maksad J, et al. Adherence to antiretroviral therapy among HIV-infected methadone patients: Effects of ongoing illicit drug use. Am J Drug Alcohol Abuse 2000;26:195-205.
20. Chesney M, Ickovics J, Chambers D, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care 2000;12:255-266.
21. Gordillo V, Del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-1769.
22. Kleeberger C, Phair J, Strathdee S, Detels R, Kingsley L, Jacobsen L. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2001;26:82-92.
23. Bouhnik A, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: The impact of social instability, J Acquir Immune Defic Syndr 2002;31(Suppl 3):S149-153.
24. Altice F, Mostashari F, Friedland G. Trust and acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001;28:47-58.
25. Morse E, Simon P, Coburn M, Hyslop N, Greenspan D, Balson P. Determinants of subject compliance with an experimental anti-HIV drug protocol. Soc Sci Med 1991;32:1161-1167.
26. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti J. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive dynamic approach. Soc Sci Med 2002;54:1481-1496.
27. Roberts K. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STDs 2000;14:155-168.
28. Hall D, Roter D, Katz N. Meta-analysis of correlates of provider behavior in medical encounters. Med Care 1998;26:657-675.
29. Chesney, M. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000;30:S171-S176.
30. Kalichman S, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med 1999;14: 267-273.
31. Ickovics J, Meisler A. Adherence in AIDS clinical trials: A framework for clinical research and clinical care. J Clin Epidemiol 1997;50:385-391.
32. Reynolds NR. Adherence to antiretroviral therapies: State of the science. Curr HIV Res 2004;2;3:207-214.
33. North Carolina Department of Health and Human Services. New AIDS cases increased in North Carolina in 2002. www.dhhs.state.nc.us/pressre1/1-22-03.htm
34. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report: HIV Infection and AIDS in the United States, 2003. http://www.cdc. gov/hiv/stats.htm (Last accessed January 6, 2005).
35. Baldwin S, Woods P. Case management and needs assessment: Some issues of concern for the caring professions. J Mental Health 1994;3:311-322.
36. Rothman J. Guidelines for Case Management: Putting Research to Professional Use. Itasca, IL: F.E. Peacock Publishers, Inc, 1992.
37. Goering P, Wasylenki D, Farkas M, Lancee W, Ballantyne R. What difference does case management make? Hosp Commun Psychiatry 1988;39:275.
38. Perlman B, Melnick G, Kentera A. Assessing the effectiveness of a case management program. Hosp Commun Psychiatry 1985;36:405.
39. Piette J, Fleishman J, Mor V, Dill A. A Comparison of hospital and community case management programs for persons with AIDS. Med Care 1990;28;8:746-755.
40. Piette J, Fleishman J, Mor V, Thompson B. The structure and process of AIDS case management. Health Soc Work 1992;17;1:47-57.
41. Piette J, Thompson B, Fleishman J, Mor V. The Organization and Delivery of AIDS Case Management. Westport, CT: Auburn House, 1993.
42. Sonsel G, Paradise E, Stroup S. Case management practice in an AIDS service organization. Soc Casework 1988;69:388-392.
43. Cruise P, Liou K. AIDS case management: A study of an innovative health services program in Palm Beach County, Florida. J Health Hum Resour Adm 1993; Summer:96-111.
44. Indyk D, Belville R, Lachapelle S, Gordon G, Dewart T. A community-based approach to HIV case management: Systematizing the unmanageable. Soc Work 1993;38;4:380-387.
45. Scott D, Hu D, Hanson I, Fleming P, Northrup T. Case management of HIV-infected children in Missouri. Public Health Rep 1995;110;3:355-357.
46. Fleishman J. Research design issues in evaluating the outcomes of case management for persons with HIV. In Evaluating HIV Case Management: Invited Research & Evaluation Papers. Washington, D.C.: Health Resources and Service Administration 1998; 25-48.
47. Lehrman S, Gentry D, Yurchak B, Freedman J. Outcomes of HIV/AIDS case management in New York. AIDS Care 2001;13;4:481-492.
48. London A, LeBlanc A, Aneshensel C. The integration of informal care, case management and community-based services for persons with HIV/AIDS. AIDS Care 1998;10;4:481-503.
49. Gardner L, Metsch L, Anderson-Mahoney P, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS 2005;4:423-431.
50. Widman M, Light D, Platt J. Barriers to out-of-hospital care for AIDS patients. AIDS Care 1994;6;1:59-67.
51. Wight R, LeBlanc J, Aneshensel C. Support service use by persons with AIDS and their caregivers. AIDS Care 1995;7:509-520.
52. Katz M, Cunningham W, Mor V, et al. Prevalence and predictors of unmet need for supportive services among HIV-infected persons: Impact of case management. Med Care 2000;38;1:58-69.
53. Bartlett J. Addressing the challenges of adherence. J Acquir Immune Defic Syndr 2002;29:(Suppl 1): S2-S10.
54. Reif S, Smith S, Golin C. Medication adherence practices of HIV/AIDS case managers: A statewide survey in North Carolina. AIDS Patient Care STDs 2003;17;9:471-481.
55. Simoni J, Frick P, Pantalone D, Turner D. Antiretroviral adherence interventions: A review of current literature and ongoing studies. Top HIV Med 2003;11; 6:185-198.
56. Golin C, Isasi F, Bontempi J, Eng E. Secret pills: HIV-positive patients' experiences taking antiretroviral therapy in North Carolina. AIDS Educ Prev 2002;14; 4:318-329.
57. Reif S, Golin C, Smith S. Barriers to accessing HIV/AIDS care in North Carolina: Rural and urban differences. AIDS Care 2005;17;5:558-565.
58. Mohammed H, Kieltyka L, Richardson-Alston G, et al. Adherence to HAART among HIV-infected persons in rural Louisiana. AIDS Patient Care STDs 2004;18;5:289-296.
59. Catz S, Kelly A, Bogart L, Benotsch E, McAuliffe T. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-133.
60. Gallant J, Block D. Adherence to antiretroviral regimens in HIV-infected patients: Results of a survey among physicians and patients. J Int Assoc Physicians AIDS Care 1998;4:32-35.
61. Gao X, Nau D, Rosenbluth S, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care 2000;12:387-398.
62. Remien R, Hirky A, Johnson M, Weinhardt L, Whittier D, Minh Le G. Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV-positive men and women in four U.S. cities. AIDS Behav 2003;7;1:61-72.
63. Roberts K, Mann T. Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care 2000;12:377-386.
64. Roca B, Gomez C, Arnedo A. Stavudine, lamivudien and indinavir in drug abusing and non-drug abusing HIV-infected patients: Adherence, side effects, and efficacy. J Infect 1999;39:141-145.
65. Wall T, Sorensen J, Bakti S, Delucchi K, London J, Chesney M. Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Drug Alcohol Depend 1995;37:261-269.
66. Weidle P, Ganea C, Irwin K, et al. Adherence to antiretroviral to antiretroviral medications in an inner-city population. J Acquir Immune Defic Syndr 1999; 22:498-502.
67. Ickovics J, Meade C. Adherence to HAART among patients with HIV: Breakthrough and barriers. AIDS Care 2002;14;3:309-318.
68. Golin C, Smith S, Reif S. Usual care adherence counseling practices among physicians, pharmacists, and case managers in North Carolina [Abstract 31860]. Paper presented at the National meeting of the Society of General Internal Medicine, San Diego, CA: 2001.